Patients should aim for adequate daily fluid intake based on individual needs, activity level, climate, and health status
Telehealth platforms, like Oana Health, offer continuous support to help you manage PCOS effectively
Continuous post-marketing surveillance is crucial to gather more extensive data "Patients should have ongoing consultations with their GP to adjust their treatment as necessary and ensure they are achieving the desired outcomes without having to deal with any adverse or manageable effects." Have a story to tell
Needle-free daily treatment Dissolves under your tongue No refrigeration needed Travel-friendly and easy to take anywhere The science behind Tirzepatide Tablets When you eat, your body naturally releases gut hormones that help regulate appetite, digestion, blood sugar, and feelings of fullness
Semaglutide GLP-1, initially developed for managing type 2 diabetes, has been FDA-approved since June 2021 for chronic weight management in adults with obesity or those who are overweight and have at least one weight-related condition such as hypertension, type 2 diabetes, or hyperlipidemia

Protocol 1: Conservative sub-therapeutic approach Goal: Target inflammation with minimal metabolic impact Starting dose: 0.5 to 1.0 mg tirzepatide weekly Escalation: Increase by 0.25 to 0.5 mg every 4 to 6 weeks based on inflammatory marker response Target maintenance: The lowest dose that produces measurable CRP/IL-6 reduction Monitoring schedule: Baseline: hsCRP, IL-6, complete metabolic panel, body weight Week 4: hsCRP, symptom assessment Week 8: hsCRP, IL-6, body weight Every 8 weeks thereafter: full inflammatory panel Duration: Minimum 12 weeks to assess response, with ongoing reassessment Best for: Normal-weight individuals with elevated inflammatory markers, autoimmune patients who cannot afford weight loss This protocol uses the compounded tirzepatide dosage calculator approach since standard vials are not designed for sub-2.5 mg dosing